12-12717990-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM1PP3
The NM_004064.5(CDKN1B):c.151G>T(p.Asp51Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,614,126 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D51G) has been classified as Uncertain significance.
Frequency
Consequence
NM_004064.5 missense
Scores
Clinical Significance
Conservation
Publications
- multiple endocrine neoplasia type 4Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, ClinGen
- multiple endocrine neoplasiaInheritance: AD Classification: STRONG Submitted by: G2P
- hereditary nonpolyposis colon cancerInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDKN1B | NM_004064.5 | c.151G>T | p.Asp51Tyr | missense_variant | Exon 1 of 3 | ENST00000228872.9 | NP_004055.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CDKN1B | ENST00000228872.9 | c.151G>T | p.Asp51Tyr | missense_variant | Exon 1 of 3 | 1 | NM_004064.5 | ENSP00000228872.4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152240Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251462 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1461886Hom.: 0 Cov.: 52 AF XY: 0.0000344 AC XY: 25AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74376 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Multiple endocrine neoplasia type 4 Uncertain:1
This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 51 of the CDKN1B protein (p.Asp51Tyr). This variant is present in population databases (rs369554045, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with CDKN1B-related conditions. ClinVar contains an entry for this variant (Variation ID: 536837). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Hereditary cancer-predisposing syndrome Uncertain:1
The p.D51Y variant (also known as c.151G>T), located in coding exon 1 of the CDKN1B gene, results from a G to T substitution at nucleotide position 151. The aspartic acid at codon 51 is replaced by tyrosine, an amino acid with highly dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at